NCT01654211View on ClinicalTrials.gov

A Pharmacokinetic And Bioavailability Study of Intravenous Danoprevir in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Healthy Volunteer
Interventions
DRUG

danoprevir

single iv infusion

DRUG

danoprevir

single oral dose

DRUG

placebo

single iv infusion

DRUG

ritonavir

oral doses

Trial Locations (1)

9471 GP

Zuidlaren

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01654211 - A Pharmacokinetic And Bioavailability Study of Intravenous Danoprevir in Healthy Volunteers | Biotech Hunter | Biotech Hunter